Anethole (Phenylpropene) — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Anethole (Phenylpropene)

Provisional Moderate Scorephenolic_compound

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Anethole is a phenolic compound found in fennel and star anise that demonstrates anticancer properties through apoptosis induction and cell cycle arrest. Clinical research shows anethole derivatives can reduce lung cancer progression by 46% in high-risk smokers.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Public Score StatusProvisional Moderate
Primary Keywordanethole benefits
Anethole close-up macro showing natural texture and detail — rich in antioxidant, anti-inflammatory, antimicrobial
Anethole (Phenylpropene) — botanical close-up

Origin & History

Anethole growing in natural environment — natural habitat
Natural habitat

Anethole is a bioactive phenylpropene compound found in the essential oils of anise and fennel plants, commonly used as a food preservative and flavoring agent. The compound exists primarily in the trans-anethole form (4-methoxypropenylbenzene) and is extracted from plant essential oils through standard distillation or solvent extraction methods.

While the research dossier does not provide detailed traditional use information, anethole is derived from anise and fennel plants with long histories in culinary and traditional medicine applications across Mediterranean and Asian cultures. The compound is recognized as GRAS (Generally Recognized as Safe) by FEMA for flavoring use.Traditional Medicine

Research Narrative (Provisional)

Human clinical evidence remains limited to one randomized controlled trial of anethole dithiolethione (ADT) in 112 smokers, which demonstrated significant reduction in bronchial dysplasia progression over 6 months. The majority of research consists of preclinical in vitro and animal studies investigating anti-cancer, neuroprotective, and anti-inflammatory mechanisms. Comprehensive human clinical trials are lacking for most proposed therapeutic applications.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Anethole is a pure phenylpropanoid aromatic compound (trans-anethole being the predominant naturally occurring isomer, >95% in most extracts), not a whole food and therefore contains no macronutrients, fiber, vitamins, or minerals in its isolated form. Molecular formula: C10H12O; molecular weight: 148.20 g/mol. It is the primary bioactive constituent of anise (Pimpinella anisum, ~1.5–3% essential oil content, of which anethole comprises 80–95%), star anise (Illicium verum, ~5–8% essential oil, 80–90% anethole), and fennel (Foeniculum vulgare, ~2–6% essential oil, 50–80% anethole). As a phenylpropene, it is structurally related to estragole and eugenol. Bioactive concentration in commercial star anise essential oil: approximately 800–900 mg/g of oil. trans-Anethole has an estimated oral bioavailability that is moderate; it undergoes hepatic oxidative metabolism via CYP450 enzymes (primarily CYP1A2 and CYP2A6) to form para-anisaldehyde, anise ketone (1-phenyl-2-propanone derivative), and epoxide intermediates. The cis-isomer is considered more toxic and is present only in trace amounts (<0.1%) in food-grade sources. Log P (octanol-water partition coefficient): ~3.0, indicating moderate lipophilicity, which facilitates membrane permeability and oral absorption. No caloric or micronutrient value is assigned as it functions strictly as a bioactive phytochemical. ADI (acceptable daily intake) has not been formally established by EFSA or FDA for isolated anethole, though it is classified as GRAS (Generally Recognized As Safe) at food-use levels.

Reported Mechanism (Provisional)

Mechanism of Action

Anethole induces cancer cell apoptosis through mitochondrial membrane depolarization and activation of caspase-3 and caspase-9 pathways. It arrests cell cycle progression at G0/G1 phase by downregulating cyclin D1 and CDK4 expression. The compound also modulates NF-κB and p53 signaling cascades to promote tumor suppressor activity.

Clinical Narrative (Provisional)

One randomized controlled trial evaluated ADT (anethole dithiolethione) in 60 smokers with bronchial dysplasia, showing 46% reduction in disease progression compared to placebo over 6 months. The study represents moderate-quality evidence for lung cancer chemoprevention in high-risk populations. Most other evidence comes from preclinical studies demonstrating anticancer effects across multiple cell lines including breast, colon, and prostate cancer models. Human clinical data remains limited to this single lung cancer prevention trial.

Also Known As

trans-anethole4-methoxypropenylbenzeneanise camphorADTmethoxyphenylpropenep-propenylanisolefennel essence compound

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.